Primary myelofibrosis is a type of blood cancer that causes a buildup of scar tissue in the bone marrow, preventing it from producing a normal amount of blood cells. Here's what you need to know about primary myelofibrosis, including symptoms, diagnosis, stages, treatment, and outlook.
Myelofibrosis is a rare bone marrow cancer. Complications may include enlarged spleen, noncancerous tumors, portal hypertension, abnormal platelet counts, severe anemia, and acute myeloid leukemia, among others. Treatments including JAK inhibitors and bone marrow transplants may help, but they aren't appropriate for everyone. Here's what you need to know to reduce your risk of myleofibrosis complications.
Myelofibrosis is a rare type of blood cancer that causes symptoms including clotting disorders, anemia, and an enlarged spleen. Learn about various myelofibrosis treatments including medications, stem cell transplants, and natural remedies, as well as ongoing clinical trials.
Myelofibrosis is a type of bone marrow cancer. It’s a progressive disease that affects each person differently — some will have severe symptoms that progress quickly, while others may live for years without showing any symptoms. Learn more about myelofibrosis, including what outlook to expect and coping strategies.